From USFDA
Dr Reddys Laboratories has received an Establishment Inspection Report from the USFDA on 11 December 2017 following closure of audit of its Formulations Manufacturing Plant 3 at Bachupally, Hyderabad by the USFDA, where in the Company received a Form 483 with 11 observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
